WHO ICTRP trial

Single-site, open, randomized clinical trial to assess the non-inferiority of…

EUCTR2018-001448-78-ES · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2018-001448-78-ES
Public title Single-site, open, randomized clinical trial to assess the non-inferiority of Cysticlean® versus Fosfomicina in the treatment of cystitis in women in Spain.
Scientific title Single-site, open, randomized clinical trial to assess the non-inferiority of Cysticlean® versus Fosfomicina in the treatment of cystitis in women in Spain.
Primary sponsor Vita Green Europa S.A.
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries Spain
Conditions Urinary Tract Infection (UTI) MedDRA version: 20.1 Level: PT Classification code 10011790 Term: Cystitis escherichia System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Female diseases of the urinary…
Interventions Trade Name: Cysticlean Product Name: Cysticlean Product Code: Cyst Pharmaceutical Form: Capsule INN or Proposed INN: cranberry extract Current Sponsor code: Cyst2018_01 Other descriptive name: CRANBERRY Concentration unit: mg milligram(s)…
Registration date Oct 25, 2018
Target size 128
Secondary IDs Cyst2018_01
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations